Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01
Published February 5, 2025 · Recall initiated: January 17, 2025
Summary
FDA records drug Class II recall D-0213-2025, published February 5, 2025 and initiated January 17, 2025. Recalling firm: McKesson; Status: Ongoing; Reported quantity: 192 vials; Lot: Lot# 04647349, Exp Date 5/31/2029. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations: Product intended for quarantine was inadvertently distributed.
What to do
Voluntary: Firm initiated · Letter
Get an email if INFLECTRA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- INFLECTRA
- Manufacturer
- McKesson
- Distributor
- Nationwide USA
- UPC
- 0300690809014
- Lot
- Lot# 04647349, Exp Date 5/31/2029
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADuloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDCFebruary 5, 2025
- FDASimple Truth Organic, BROCCOLI FLORETS, STEAM IN BAG, 12oz, BEST IF USED BY NOV 08 2024, PRODUCT OF MEXICOFebruary 5, 2025
- FDAPrograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by:February 5, 2025
- FDA13 oz. Lay's Classic Potato Chips.February 5, 2025
- FDAAstagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan,February 5, 2025
- FDACorfu Tzatziki sauce packaged in half gallon plastic tubs, 4 tubs per case. Mediterranean Tzatziki sauceFebruary 5, 2025
Questions about this recall
Was Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01 recalled?
Yes. FDA published recall D-0213-2025 on February 5, 2025. Reported hazard: cGMP Deviations: Product intended for quarantine was inadvertently distributed.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: INFLECTRA. UPC: 0300690809014.